Connect with us

Lonasen (blonanserin)

Blonanserin (or LONASEN®) is mainly prescribed to treat schizophrenia and bipolar disorder.

PMDA Approval: 2008 (International: Japan, Korea)

Dosage Forms: 2 mg, 4 mg, 6 mg, 8 mg, 12 mg, 14 mg, 16 mg

Biological Half-life: 12 hours

Side Effects: Dizziness, weight gain, movement problems, anxiety, irritability

Routes of Administration: Oral

Pregnancy Category: N/A

  www.ds-pharma.com

Like Us

Advertisement
Advertisement